Healthcare Jan 28, 2023 11:20 AM (GMT+8) · EqualOcean
YingHe Neuro (Chinese: 应和脑科学) announced that it had completed a CNY 100 million Angel round co-led by BioChing Capital (Chinese: 邦勤资本) and LAV (Chinese: 礼来亚洲基金) and followed by Snibe Diagnostic (Chinese: 新产业生物), XiJiao 1896 innovation fund (Chinese: 西交一八九六科创基金), and its existing backer Enlight Medical (Chinese: 应脉医疗). DeepSnow Capital (Chinese: 深雪资本) acted as the financial adviser. YingHe Neuro focuses on the development of a new generation of neuromodulation and brain-computer interface products and technologies based on clinical demands.